Grade 3-4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation

被引：7
|
作者：
Modi, Dipenkumar [1 ]
Albanyan, Omar [1 ]
Kim, Seongho [2 ]
Deol, Abhinav [1 ]
Ayash, Lois [1 ]
Ratanatharathorn, Voravit [1 ]
Uberti, Joseph P. [1 ]
机构：
[1] Wayne State Univ, Dept Oncol, Barbara Ann Karmanos Canc Inst, 4100 John R,HW04H0, Detroit, MI 48201 USA
[2] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Oncol, Biostat Core, Detroit, MI USA
来源：
LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 08期
关键词：
Cytokine release syndrome; tocilizumab; haploidentical donor transplant; noninfectious fever; post-transplant cyclophosphamide (PTcy); FEBRILE REACTION; CYCLOPHOSPHAMIDE; MARROW; ENGRAFTMENT; INFUSION;
D O I：
10.1080/10428194.2021.1891231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The information on the impact of cytokine release syndrome (CRS) on haploidentical donor peripheral blood stem cell transplant (haploPBSCT) outcomes is limited. We retrospectively evaluated 98 patients who underwent haploPBSCT between June 2012 and June 2019 for the onset and severity of CRS per the ASTCT guidelines. The incidence of CRS was 93% (91/98). Outcomes were compared between grade 1-2 and 3-4 CRS. Eighty-one patients developed grade 1-2 CRS (89%) and 10 (11%) developed grade 3-4 CRS. Compared to grade 1-2 CRS, grade 3-4 CRS experienced adverse survival (73.7% vs. 30%, p<.001), inferior relapse-free survival (64.0% vs. 20%, p<.001), and higher non-relapse mortality (NRM) (16.4% vs. 60%, p<.001) at 1-year. Propensity score-based multivariable analyses revealed worse survival (HR 2.71, p=.04), and higher NRM (SHR 4.51, p=.006) with grade 3-4 CRS. Our study shows that grade 3-4 CRS was adversely associated with survival. Therefore, early identification and preventive strategies are warranted.
引用
收藏
页码：1982 / 1989
页数：8
相关论文
共 50 条
  • [1] Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell
    Bouchacourt, Benjamin
    Maisano, Valerio
    Benzaquen, Ana
    Granata, Angela
    Furst, Sabine
    Legrand, Faezeh
    Pagliardini, Thomas
    Loron, Sandrine
    Harbi, Samia
    Weiller, Pierre-Jean
    Mozziconacci, Marie-Joelle
    Lemarie, Claude
    Calmels, Boris
    Chabannon, Christian
    Blaise, Didier
    Devillier, Raynier
    BLOOD, 2021, 138
  • [2] Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
    Imus, Philip H.
    Blackford, Amanda L.
    Bettinotti, Maria
    Luznik, Leo
    Fuchs, Ephraim J.
    Huff, Carol Ann
    Gladstone, Douglas E.
    Ambinder, Richard F.
    Borrello, Ivan M.
    Fuchs, Robert J.
    Swinnen, Lode J.
    Wagner-Johnston, Nina
    Gocke, Christian B.
    Ali, Syed Abbas
    Bolanos-Meade, F. Javier
    Jones, Richard J.
    Dezern, Amy E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) : 2431 - 2437
  • [3] Risks and Outcomes of Cytokine Release in Haploidentical Peripheral Blood Stem Cell Transplantation
    Imus, Philip Hollingsworth
    Blackford, Amanda
    Franklin, Clio
    Jones, Richard J.
    DeZern, Amy E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S298 - S299
  • [4] Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
    Otoukesh, Salman
    Elmariah, Hany
    Yang, Dongyun
    Clark, Mary C.
    Siraj, Madiha
    Ali, Haris
    Mogili, Krishnakar
    Arslan, Shukaib
    Nishihori, Taiga
    Nakamura, Ryotaro
    Pidala, Joseph
    Marcucci, Guido
    Forman, Stephen J.
    Anasetti, Claudio
    Al Malki, Monzr M.
    Bejanyan, Nelli
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (02): : 111.e1 - 111.e8
  • [5] Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation
    Teachey, David T.
    Grupp, Stephan A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1736 - 1737
  • [6] Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With PostTransplant Cyclophosphamide: Time of Onset Matters
    Hernandez-Sanchez, Alberto
    Cabero, Almudena
    Fonseca, Marta
    Puertas, Borja
    Gomez, Sandra
    Alonso, David
    Alejo, Elena
    Puerta, Carlos
    Garcia, Pablo
    Pablos, Alicia
    Pena, Felipe
    Cabrero, Monica
    Avendano, Alejandro
    Baile, Monica
    Martin, Ana Africa
    Perez, Estefania
    Lopez, Miriam
    Marcos, Sara
    Prieto, Laura
    Vazquez, Lourdes
    Sanchez-Guijo, Fermin
    Caballero, Ma Dolores
    Lopez-Corral, Lucia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S437 - S438
  • [7] Incidence and Severity of Cytokine Release Syndrome Following Haploidentical Peripheral Blood Stem Cell Infusion
    Cirrone, Frank
    Pavlonnis, Jamie
    Cole, Kelli
    Abdul-Hay, Maher
    Park, Doyun
    Al-Homsi, A. Samer
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 605 - 606
  • [8] CYTOKINE RELEASE SYNDROME AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND ITS IMPACT ON OVERALL SURVIVAL
    Pimentel Pittol, Isabella Silva
    Isoppo, Camila Carminatti
    Americo, Andre Dias
    De Medeiros Lima, Germano Glauber
    da Rosa, Eurides Leite
    Goncalves Garreta Prats, Joao Antonio
    Rodrigues Figueroa, Hegta Taina
    Pessoa, Juliana Matos
    Scheinberg, Phillip
    Ayoub, Fauze Lutfe
    Kerbauy, Fabio Rodrigues
    BONE MARROW TRANSPLANTATION, 2024, 59 : 560 - 561
  • [9] CTLA4Ig Limits Both Incidence and Severity of Early Cytokine Release Syndrome following Haploidentical Peripheral Blood Stem Cell Transplantation
    Jaiswal, Sarita Rani
    Chakrabarti, Suparno
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : E86 - E87
  • [10] Cytokine release syndrome after peripheral blood haploidentical stem cell transplantation with post-transplant cyclophosphamide: time of onset matters
    Hernandez Sanchez, A.
    Cabero Martinez, A.
    Fonseca Santos, M.
    Puertas Martinez, B.
    Gomez Ubeda, S.
    Alonso Castronuno, D.
    Alejo Alonso, E.
    Puerta Vazquez, C.
    Garcia Jaen, P.
    Pablos Lopez, A.
    Pena Munoz, A. F.
    Cabrero Calvo, M.
    Avendano Pita, A.
    Baile Gonzalez, M.
    Martin Lopez, A. A.
    Perez Lopez, E.
    Lopez Parra, M.
    Marcos Asensio, S.
    Marcos Corrales, S.
    Prieto Garcia, L.
    Sanchez-Guijo Martin, F.
    Vazquez Lopez, L.
    Caballero Barrigon, M. D.
    Lopez Corral, L.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 78 - 78
12345